MACE (major adverse cardiac events)

FREE subscriptions for doctors and students... click here
You have 3 more open access pages.

  • term MACE, defined as 'major adverse cardiac events,' is arguably the most commonly used composite end point in cardiovascular research
    • term MACE appears to have originated in the mid-1990s with its use restricted primarily to in-hospital complications related to percutaneous coronary interventions

  • there is no standard definition of MACE, it is routinely used and reported for procedural, short-term, and long-term outcome evaluations, and may involve other cardiovascular treatments (2)

  • a review (2) suggested that 'Varying definitions of composite end points, such as MACE, can lead to substantially different results and conclusions. Therefore, the term MACE, in particular, should not be used, and when composite study end points are desired, researchers should focus separately on safety and effectiveness outcomes, and construct separate composite end points to match these different clinical goals...'


Last reviewed 01/2018